Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diazoxide and Hypothalamic Activation in T2D
NCT03566511Phase 2Terminated
- Start
- Jun 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of diazoxide in type 2 diabetes mellitus (T2DM). Started Jun 2018; status: terminated.
02
Drugs
diazoxide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03566511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03566511.